Last week, an FDA advisory committee evaluated whether the agency should allow pharmacies to produce popular peptides and sell them to consumers. We explain the benefits and risks of these changes @science.org www.science.org/content/arti...
FDA committee votes to make peptides more widely available
The loosely regulated molecules could soon become easier to buy, despite unknowns about their risks
science.org